We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Vitamin D Assays Compared and Harmonized

By LabMedica International staff writers
Posted on 06 Jun 2017
Print article
Image: The complete extraction-free, fully automated Liaison XL 1,25 dihydroxyvitamin D radioimmunoassay kit (Photo courtesy of DiaSorin).
Image: The complete extraction-free, fully automated Liaison XL 1,25 dihydroxyvitamin D radioimmunoassay kit (Photo courtesy of DiaSorin).
There are a variety of assay techniques available to measure of 25-hydroxyvitamin D (25(OH)D) concentrations and some have the ability to measure the two forms 25(OH)D2 and 25(OH)D3. However, there are significant discrepancies between procedures used to estimate vitamin D status.

Vitamin D is a prohormone and is mostly obtained through skin synthesis from UVB exposure, and as such shows strong seasonal trends. Vitamin D can be obtained in two isoforms, and while UVB exposure-related synthesis will always lead to formation of cholecalciferol (D3), in diet or dietary supplements, vitamin D can also exist as egrocalciferol (D2).

Scientists at the University of South Australia (Adelaide, Australia) and their international colleagues measured concentrations of 25(OH)D3 and 25(OH)D2 using liquid chromatography–tandem mass spectrometry (LC-MS/MS) in 5,915 participants (aged 31 years) of Northern Finland Birth Cohort 1966. Blood samples were assayed in batches over a course of 18 months. As anomalies were present in the measurements, 200 samples were reassayed using a radioimmunoassay.

Samples were prepared for analysis by thawing, mixing and re-centrifuging, to remove any fibrin debris. The integrated high performance liquid chromatography (HPLC) system used to separate the peaks of interest was the Acquity Ultra Performance Liquid Chromatography system. The radioimmunoassay Vitamin D kit was obtained from DiaSorin. To harmonize LC-MS/MS with Diasorin RIA measurements, formulae were derived from the limits of agreement (LoA).

The team found that concentrations of Vitamin D measured by LC-MS/MS were much higher than those measured by DiaSorin RIA, with a mean difference of 12.9 ng/mL. Constant variation was evident between batch measurements after log transformation. Statistical formula was applied separately for each batch of LC-MS/MS measurements, enabling the scientists to remove both the constant and proportional bias that was evident prior to the transformation.

The authors concluded that despite the introduction of schemes and or programs to improve accuracy of assays to measure 25(OH)D, significant differences can still happen. In these instances, methods to harmonize measurements based on a relatively small number of replicates can be successfully applied to establish confidence and to enable between-study comparisons. However, despite achieving better agreement between the methods by the statistical harmonization of 25(OH)D concentrations, any use of these data for developing population health guidelines should be done with caution. The study was published on May 17, 2017, in the Journal of Clinical Laboratory Analysis.

Related Links
University of South Australia

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb

Print article

Channels

Molecular Diagnostics

view channel
Image: The test can find tRNA fragments unique to Parkinson’s disease before patients even have symptoms (Photo courtesy of Shutterstock)

Rapid Blood Test Identifies Pre-Symptomatic Patients with Parkinson’s Disease

Currently, no reliable blood test exists for diagnosing Parkinson’s disease. Instead, physicians rely on observing a patient's movements, but this qualitative method has an error rate of 20%-25% and can... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.